The AAP has issued new guidelines for the prevention and control of influenza in children.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
ACIP: New members meeting June 25-26; AAP liaisons not participating
The American Academy of Pediatrics will continue to hold its own childhood vaccine schedule, as it has since the 1930s.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Octavio Ramilo, MD, joins us once again to discuss potential benefits of RSV vaccination beyond disease prevention, and to explain how to speak with patients about vaccines and uptake.
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
FDA expands glecaprevir/pibrentasvir indication for acute hepatitis C down to 3 years of age
Glecaprevir/pibrentasvir was a "highly efficacious treatment for people with acute HCV," with 96.2% of patients analyzed having sustained virological response 12 weeks post-treatment.
FDA approves clesrovimab to protect infants during first RSV season
The BLA for clesrovimab was based on results demonstrated in the phase 2b/3 CLEVER trial among healthy pre-term and full-term infants.